Kalion is a biotech company that manufactures high-purity chemicals for the pharmaceutical markets.
Kalion is an early stage industrial biotech company that will transform the traditional chemical industry by providing low-cost access to glucaric acid and S-3-hydroxybutyrolactone (3-HBL) using traditional, green, fermentation technology. Glucaric acid and 3-HBL were identified as “Top Value Added Chemicals from Biomass” and multi-billion dollar markets for use of the two chemicals are limited by cost and availability (2004 DOE report).
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 18, 2020 | Grant | $0.94M | 1 |
National Science Foundation
|
— | Detail |
| May 22, 2018 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Jun 22, 2015 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |